These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4641856)

  • 1. Rejection of ascites tumor allografts. II. A pathway for cell-mediated tumor destruction in vitro by peritoneal exudate lymphoid cells.
    Berke G; Sullivan KA; Amos B
    J Exp Med; 1972 Dec; 136(6):1594-604. PubMed ID: 4641856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rejection of ascites tumor allografts. I. Isolation, characterization, and in vitro reactivity of peritoneal lymphoid effector cells from BALB-c mice immune to EL4 leukosis.
    Berke G; Sullivan KA; Amos B
    J Exp Med; 1972 Jun; 135(6):1334-50. PubMed ID: 5025438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Temperature control of lymphocyte-mediated cytotoxicity in vitro.
    Berke G; Sullivan KA
    Transplant Proc; 1973 Mar; 5(1):421-3. PubMed ID: 4695950
    [No Abstract]   [Full Text] [Related]  

  • 4. Macrophage dependent protection of tumour cells.
    Hersey P; MacLennan IC
    Immunology; 1973 Feb; 24(2):385-93. PubMed ID: 4714057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour resistance of mice infected with salmonella enteritidis 11RX. The role of peritoneal exudate cells.
    Ashley MP; Hardy D
    Aust J Exp Biol Med Sci; 1973 Dec; 51(6):801-9. PubMed ID: 4596243
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumor immunity in vitro: destruction of a mouse ascites tumor through a cycling pathway.
    Berke G; Sullivan KA; Amos DB
    Science; 1972 Aug; 177(4047):433-4. PubMed ID: 5043143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nature of lymphocyte-tumor interaction. A general method for cellular immunoabsorption.
    Stulting RD; Berke G
    J Exp Med; 1973 Apr; 137(4):932-42. PubMed ID: 4632629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic lymphocytes in the absence of detectable antibody.
    Berke G; Amos DB
    Nat New Biol; 1973 Apr; 242(121):237-9. PubMed ID: 4540806
    [No Abstract]   [Full Text] [Related]  

  • 9. Activity of tumor-associated lymphoid cells at short intervals after administration of irradiated syngeneic and allogeneic tumor cells.
    Schick B; Berke G
    J Immunol; 1977 Mar; 118(3):986-91. PubMed ID: 321684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of cell-mediated immunity against leukemia EL4 in C57BL mice.
    Kemp A; Berke G; Crowell J; Amos B
    J Natl Cancer Inst; 1973 Dec; 51(6):1877-82. PubMed ID: 4765391
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunologic aspects of murine allogeneic tumor growth (author's transl)].
    Braun M; Saal F; Pasqualini CD
    Sangre (Barc); 1974; 19(2):153-7. PubMed ID: 4409784
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro reactivity of macrophages and lymphocytes from ultraviolet-irradiated mice.
    Norbury KC; Kripke ML; Budmen MB
    J Natl Cancer Inst; 1977 Oct; 59(4):1231-5. PubMed ID: 903998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response of BALB/c X DBA/2F1 mice to a tumor allograft during pyran copolymer-induced tumor enhancement.
    Schultz RM; Woods WA; Mohr SJ; Chirigos MA
    Cancer Res; 1976 May; 36(5):1641-6. PubMed ID: 1268825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early steps in specific tumor cell lysis by sensitized mouse T lymphocytes. I. Resolution and characterization.
    Martz E
    J Immunol; 1975 Jul; 115(1):261-7. PubMed ID: 50350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transplantable ascitic tumor derived from a mouse with moloney sarcoma: tumorigenic, antigenic and virologic properties (author's transl)].
    Weiland E; Weiland F
    Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):151-61. PubMed ID: 4283271
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor-associated lymphoid cells: analysis of host cells that bind to syngeneic and allogeneic tumor cells shortly after tumor administration.
    Schick B; Berke B
    Transplant Proc; 1977 Mar; 9(1):1157-60. PubMed ID: 867485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional efficiency of antitumor cytotoxic lymphoid cells.
    Wunderlich JR; Martin WJ; Macdonald J
    Isr J Med Sci; 1973 Mar; 9(3):317-23. PubMed ID: 4710039
    [No Abstract]   [Full Text] [Related]  

  • 18. In vivo activity of in vitro immunized lymphocytes. I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes.
    Rouse BT; Wagner H; Harris AW
    J Immunol; 1972 May; 108(5):1353-61. PubMed ID: 4623947
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of tumor cell resistance to syngeneic cell-mediated cytotoxicity during growth of ascitic mastocytoma P815Y.
    Biddison WE; Palmer JC
    Proc Natl Acad Sci U S A; 1977 Jan; 74(1):329-33. PubMed ID: 402006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of effector T lymphocyte subpopulations necessary to mediate semisyngeneic tumor rejection in mice].
    Keyaki A
    Nihon Geka Hokan; 1985 Nov; 54(6):460-77. PubMed ID: 3879662
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.